StockData
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30

PHIBRO ANIMAL HEALTH CORP

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 26, 2026
$39.34+0.52 (+1.34%)

Close on Oct 19, 2026

Market cap
$1.61B
P/E (TTM)
16.2
Dividend yield
1.22%

Dividends

Dividend declared per share by fiscal year, adjusted for stock splits

Per share, FY2026
$0.48
0.0% on the prior year
Consecutive increases
0 years
Not raised last year
Dividend yield
1.22%
Latest annual dividend ÷ share price
Payout ratio, FY2026
19.5%
Dividends paid ÷ net income

Dividend history

By fiscal year

Fiscal yearPer shareChangeCash paidPayout ratio
FY2026$0.480.0%$19.46M19.5%
FY2025$0.480.0%$19.45M40.3%
FY2024$0.480.0%$19.44M804.7%
FY2023$0.480.0%$19.44M59.6%
FY2022$0.480.0%$19.44M39.5%
FY2021$0.480.0%$19.43M35.7%
FY2020$0.48+4.3%$19.42M57.9%
FY2019$0.46+15.0%$18.59M34.0%
FY2018$0.400.0%$16.07M24.8%
FY2017$0.400.0%$15.83M24.5%
FY2016$0.400.0%$15.71M19.0%
FY2015$0.40-51.2%$15.60M25.9%
FY2014$0.82+720.0%$25.00M-799.5%
FY2013$0.10–$3.00M12.1%

Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.